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Resources that physiotherapists could use to add value to their research
Mark R Elkins
Editor, Journal of PhysiotherapyMany documents have been developed to help clinical
researchers at various stages of their research. Some are intended
to help when designing the research, while others are intended to
help ensure that the research is ethically conducted. Another large
group of documents are those that are intended to help researchers
to publish their research[1_TD$DIFF] with the necessary details for others to
appraise and use [9_TD$DIFF] it appropriately. The purpose of this editorial is
to encourage physiotherapy researchers to view these documents
as an opportunity to add value to their research at the various
stages before publication.
Readers may be familiar with some of these documents. For
example, the Declaration of Helsinki is a set of ethical principles
governing research involving humans, which was developed by
the World Medical Association.1 Many trial reports include a
statement that the research was ‘conducted in accordance with
the Declaration of Helsinki’, but the reported methods sometimes
show that this is not true. Perhaps these researchers read the
Declaration of Helsinki many years ago and believe that it has not
changed. However, it has been [10_TD$DIFF]amended seven times since the
original 1964 version. The most recent update was in 2013, so
even researchers who have read it relatively recently may ﬁnd
that it has changed.2 Although fundamental ethical principles
may change very infrequently, ethical implications of new
developments in the world need to be incorporated. One such
amendment was made in accordance with the introduction of
clinical trial registers and the various campaigns to encourage
prospective registration of randomised trials.3,4 [11_TD$DIFF] he Declaration
of Helsinki [12_TD$DIFF]now [13_TD$DIFF]states:
[14_TD$DIFF]Every research study [15_TD$DIFF] not just randomised trials [16_TD$DIFF] must be
registered in a publicly accessible database before recruitment of
the ﬁrst subject.
Yet researchers still submit manuscripts to the Journal of
Physiotherapy reporting unregistered studies and claiming consis-
tency with the Declaration of Helsinki. All authors are reminded
that to be considered by the Journal of Physiotherapy and many
other physiotherapy journals, manuscripts reporting randomised
trials starting in 2006 or latermust be prospectively registered.3 By
following the Declaration of Helsinki’s recommendation to
prospectively register all types of studies, a researcher would
make his/her studies more appealing to editors, reviewers and
readers because it proves that the research is not biased [17_TD$DIFF]by, eg,
selective reporting of outcomes[3_TD$DIFF].3 Researchers may also be
surprised to learn that the Declaration of Helsinki states that:
In advance of a clinical trial, sponsors, researchers and host country
governments should make provisions for post-trial access for all
participants who still need an intervention identiﬁed as beneﬁcial
in the trial.1836-9553/ 2015 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).Some physiotherapy trials achieve this recommendation by
using a ‘wait list’ design, where the control group is offered the
treatment after the trial.5 In other physiotherapy trials, post-trial
provision of the intervention is not possible. For example,
interventions that are beneﬁcial when administered before surgery
may not[4_TD$DIFF] be applicable postoperatively.6,7 An intervention applied
with the intention of shortening the duration of inpatient
management may have no subsequent purpose in the control
group.8,9 Nevertheless, many trials that could provide the interven-
tion after the data collection period do not do so. This itemwas later
clariﬁed with:
It is necessaryduring the studyplanning process to identify post-trial
access by study participants to prophylactic, diagnostic and
therapeutic procedures identiﬁed as beneﬁcial in the study or access
to other appropriate care. Post-trial access arrangements or other
care must be described in the study protocol so the ethical review
committee may consider such arrangements during its review.
Many interpret this as a requirement[5_TD$DIFF] to identify whether or not
post-trial access to the interventionwill be available, meaning that
there is no real onus to do so.10 Nevertheless, researchers could use
theDeclaration of Helsinki to remind themselves of the importance
of this issue and incorporate post-trial provision of the interven-
tion, where possible. In addition to improving the trial’s ethical
standard, it may improve the scientiﬁc standard by fostering
recruitment andminimising loss to follow-up in the control group.
Reporting guidelines are another type of resource that
physiotherapists could use to add value to their research. These
documents are designed to help clinical researchers to publish all
of the details of a research study that readers will need to
understand its methods, judge its quality, and appropriately apply
the results. There are many reporting guidelines related to speciﬁc
types of research. For example, researchers who are writing a
manuscript about a randomised trial could use the Consolidated
Standards of Reporting Trials (CONSORT) statement.11 The
statement is summarised into a checklist, which authors can use
to identify where in their manuscript each item of the CONSORT
statement is reported. The completed checklist can also be
submitted with the manuscript for the beneﬁt of reviewers and
editors. The Journal of Physiotherapy has supported the use of
reporting guidelines for over a decade and recently co-published
an editorial reiterating their importance.12
Unfortunately, as with the Declaration of Helsinki, published
reports of research often reveal that these reporting guidelines
have not been used as theywere intended. For example, the Journal
of Physiotherapy regularly receives manuscripts that report a
randomised trial and state that ‘the CONSORT statement was used
to guide reporting’, but the appropriate items still do not appear in
the paper. This is a problem but, at least at the editorial stage, it is.V. This is an open access article under the CC BY-NC-ND license (http://
Editorial104ﬁxable. However, it suggests that some researchers view the
CONSORT statement as an administrative hurdle. It may be more
valuable to view it as a resource that they can use to ensure that
their research is reported in enough detail to be useful to clinicians
and other researchers.
A less ﬁxable problem is heralded by the statement that ‘the
CONSORT statement was used to guide the design of the trial’. The
CONSORT statement is a reporting guide, not a design guide.
Although many items on the CONSORT checklist are relevant for
consideration at the design stage, researcherswho use it in thisway
risk missing crucial advice about how to[6_TD$DIFF] design their clinical trial[18_TD$DIFF]
well. Consider the issue of loss to follow-up in clinical trials, for
example. In a sample of over 10 000 trials of physiotherapy
interventions,more thanhalf of the trials failed to follow-up at least
85% of their original participants.13 However, trials can be designed
to incorporate strategies that minimise loss to follow-up.14
Incorporation of these strategies into the trial design is recom-
mended in the guide to preparing a trial protocol, known as the
SPIRIT statement (Standard Protocol Items: Recommendations for
Interventional Trials).15 On this issue of follow-up, the SPIRIT
statement provides helpful discussion of issues such as: choosing
the trial’s duration to maximise clinically relevant outcome
measurement while minimising loss to follow-up; and which
strategies have been proven to minimise loss to follow-up. It is too
late to do anything about loss to follow-up at the reporting stage.
Accordingly, the CONSORT statement only advises about clear
reporting of the extent of the follow-up, such as distinguishing
unavoidable loss to follow-up from investigator-determined
exclusion. Other guidelines that could be used at the design stage
are those intended to help researchers in choosing thebest outcome
measures to use in their trials. As examples, the OutcomeMeasures
in Rheumatology (OMERACT) website could be used by researchers
in arthritis (www.omeract.org), and the Initiative on Methods,
Measurement, and Pain Assessment in Clinical Trials (IMMPACT)
websitehasdocuments to guidepain research (www.immpact.org).
Although randomised trials have been used as an example
above, equivalent documents are also available for other study
designs: observational studies, systematic reviews, qualitative
studies, diagnostic studies, prognostic studies, economic evalua-
tions, and so on. Researchers can ﬁndmany of these documents on
the Equator Network website[19_TD$DIFF].
As well as the main reporting guideline for each study type, the
Equator Network also compiles extension documents. These are
companion documents with extra detail that is only pertinent (but
still very valuable) to some studies with a particular characteristic.
For example, there is an extension to the CONSORT statement that
is speciﬁcally designed for non-pharmacologic interventions.16
This is particularly relevant to physiotherapy intervention trials,
because it more thoroughly addresses issues such as the difﬁculty
of blinding physical interventions and the importance of reporting
the skills, experience and any speciﬁc extra training of the
physiotherapists who apply the study interventions such as
manual techniques. Despite its relevance to physiotherapy, few
authors mention this document in their published trial reports.
As noted above, one of the areas in which the CONSORT
statement is too cursory is in its guidance about what intervention
details to include in the published trial report. Speciﬁcally, the
CONSORT statement only states:
Describe the intervention for each group with sufﬁcient details to
allow replication, including how and when they were assessed.11
This lacks detail for a researcher who wants to ensure that they
include all the necessary[7_TD$DIFF] details[20_TD$DIFF] of an intervention for clinical
physiotherapists to be able to apply it to their patients. But it isn’t
just the CONSORT statement; it is a problem that has affected
several of the reporting guidelines[8_TD$DIFF] to some extent. This deﬁciency
may explain the recent ﬁnding that 89% of published trial reports
lack enough detail for the intervention to be replicated.17 To rectify
this, the Equator Network has recently added an extension
document called the Template for Intervention Description andReplication (TIDieR).18 It also comes with a checklist containing
explicit instructions such as:
Describe the number of times the intervention was delivered and
over what period of time, including the number of sessions, their
schedule, and their duration, intensity or dose
and
If the intervention was planned to be personalised, titrated or
adapted, then describe what, why, when, and how.
That is, it guides a researcher to include all the practical
information that clinicians need to apply the study’s intervention.
The TIDieR checklist is designed to be used in conjunction with
checklists for any study types that involve an intervention. This
would include the CONSORT and SPIRIT statements for randomised
trials, but could also apply to the reporting guidelines for
observational studies where the participants are receiving an
intervention, a case report of a patient who was receiving a
treatment, systematic reviews of such studies, and so on. In this
way, the TIDieR checklist can help researchers to overcome cursory
guidance about reporting interventions in these other checklists,
ensuring that the reporting of the intervention is thorough.
Some other resources have been developed to guide research-
ers on some specialised research issues outside the Equator
Network. A recent example is the second version of the Pragmatic-
Explanatory Continuum Index Summary (PRECIS-2).19 This tool
helps researchers to understand how different aspects of a trial’s
design inﬂuencewhether that trial estimates efﬁcacy (the effect of
an interventionwhen it is administered exactly as intended, ie, an
explanatory trial) or effectiveness (the effect of the intervention
when applied in everyday clinical practice where factors such as
poor adherence potentially reduce its effect, ie, a pragmatic
trial).20
Guides for reporting are not strictly limited to clinical research.
The Guideline for Reporting Evidence-based practice Educational
interventionsandTeaching (GREET)hasbeendevelopedtoguide the
reporting of educational interventions for developing foundational
knowledge and skills in evidence-based practice.21 Like TIDieR,
GREET can be used in conjunctionwith checklists such as CONSORT
to ensure thorough reporting of the educational intervention.
The ﬁnal point to make is that these documents are helpful. For
example, since the CONSORT statement22 was published, there has
been improved reporting of many of the items it recommends for
physiotherapy trial reports.13 Researchers should consider them as
valuable resources to improve their research, not just as extra
paperwork. Some junior researchers even say the checklists help
them to overcome difﬁculty in knowing where to start when
writing a study protocol or report. Therefore, researchers are
encouraged to explore each document that is available in relation
to their current and future studies, to read and use each document
carefully – and most crucially – to ensure that each document is
used for its intended purpose.
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http://dx.doi.org/10.1016/j.jphys.2015.05.012People’s Choice Award for 2014The Editorial Board is pleased to introduce the annual People’s Choice Award, which recognises the paper published in Journal of
Physiotherapy that generates the most interest by readers of the journal. The winning paper is chosen based on the number of times that
each paper published in a given year is downloaded in the six months after its day of publication.
Thewinning paper is ‘Current evidence does not support the use of Kinesio Taping in clinical practice: a systematic review’ by Patrı´cia do
Carmo Silva Parreira and colleagues from the Universidade Cidade de Sa˜o Paulo in Brazil.1 This systematic review examined the 12
randomised trials that provided published data by June 2013 about the effect of Kinesio Taping on pain, disability, quality of life, return to
work and global perceived recovery in people with musculoskeletal conditions. These trials provided data on 495 participants. Studies
were excluded if they were conducted on healthy participants or only reported data on physical performance (eg, vertical jump test). The
12 trials covered a range of musculoskeletal conditions. Among these trials, Kinesio Taping had no beneﬁt over sham taping or other active
treatments towhich it had been compared, the beneﬁtwas too small to be clinicallyworthwhile, or the trials were of low quality. Therefore
the evidence did not support the use of Kinesio Taping for musculoskeletal conditions.
The Journal of Physiotherapy has subsequently received and published two more high-quality randomised trials comparing Kinesio
Taping to sham taping: one for swelling after ankle sprain by Nunes and colleagues2 and one for low back pain, which again has Patrı´cia do
Carmo Silva Parreira as the ﬁrst author.3 These two trials further reinforce the ﬁndings of the review by demonstrating that Kinesio Taping
was no better than sham taping for these conditions.
The winning paper also generated the highest activity on social media among the papers published in 2014. The Editorial Board of
Journal of Physiotherapy congratulates Patrı´cia do Carmo Silva Parreira and colleagues on their success.References1. Parreira PdCS. Costa LdCM. Hespanhol Junior LC, Lopes AD, Costa LOP. Current evidence does not support the use of Kinesio Taping in clinical practice: a systematic review.
J Physiother. 2014;60:31–39.
2. Nunes GS, Vargas VZ, Wageck B, dos Santos Hauphental DP, da Luz CM, de Noronha M. Kinesio Taping does not decrease swelling in acute, lateral ankle sprain of athletes:
a randomised trial. J Physiother. 2015;61:28–33.
3. Parreira PCS, Costa LCM, Takahashi R, Hespanhol Junior LC, da Luz Junior MA, da Silva TM, Costa LOP. Kinesio Taping to generate skin convolutions is not better than sham taping
for people with chronic non-speciﬁc low back pain: a randomised trial. J Physiother. 2014;60:90–96.http://dx.doi.org/10.1016/j.jphys.2015.05.010
